End-Stage Renal Disease

End-Stage Renal Disease News


End-Stage Renal Disease Perspective

  • Advancing American Kidney Health: The Ultimate RCT? President Trump's Executive Order puts nephrology center stage. Tejas Desai, MD, reviews what the initiative entails for kidney disease clinicians and what details are yet to come.
  • How Do the Renal Data From CREDENCE and CARMELINA Compare?   Meg Jardine and Christoph Wanner, investigators from the CREDENCE and CARMELINA trials, respectively, discuss the implications for SGLT2 inhibitor and DPP-4 inhibitor use in patients with kidney disease.